This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...